HHealthcare Read More Sickle cell gene therapies offer new hope, accessing them is hardOctober 16, 2026 This microscope photo provided on Oct. 25, 2023, by the Centers for Disease Control and Prevention shows crescent-shaped…
HHealthcare Read More For final 10% of cystic fibrosis patients, breakthrough hasn’t comeOctober 14, 2026 Emily Kramer-Golinkoff founded Emily’s Entourage in 2011 to speed up research for the final 10% of CF patients.…
HHealthcare Read More What a mom and CEO tells her kids every day amid all the AI cheatingOctober 14, 2026 CNBC is now accepting nominations for the 2027 Changemakers List. Kate Ryder has no doubts about the extent…
HHealthcare Read More Johnson & Johnson (JNJ) earnings Q3 2026October 13, 2026 Johnson & Johnson reported a slightly higher-than-expected profit on Tuesday, driven by strong sales of its immune disease…
HHealthcare Read More UnitedHealth Group (UNH) earnings Q3 2026October 13, 2026 UnitedHealth Group signage on the floor of the New York Stock Exchange on April 21, 2025. Michael Nagle…
MMedication Read More Eli Lilly obesity drug with amylin, tirzepatide boosts weight loss in trialOctober 2, 2026 Eli Lilly on Wednesday said its experimental combination regimen resulted in greater weight loss than a high dose…
MMedication Read More Novo’s Wegovy pill improves weight loss after switch from injectionsSeptember 30, 2026 People who switched from obesity injections to Novo‘s new Wegovy pill continued to lose weight after three months,…
HHealthcare Read More Why we like Starbucks’ latest turnaround move — plus, two more wins for Eli LillySeptember 25, 2026 Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just…
HHealthcare Read More Novo Nordisk CEO on rebuilding investor trust after backlashSeptember 24, 2026 Novo Nordisk CEO Maziar Mike Doustdar waits for the start of the pharmaceutical company’s annual general meeting in…
HHealthcare Read More Eli Lilly CEO David Ricks discusses GLP-1s and Medicare coverageSeptember 21, 2026 Eli Lilly CEO Dave Ricks told CNBC on Monday that 700,000 new seniors have started GLP-1 treatments since…
HHealthcare Read More Lilly is ramping up future manufacturing for Foundayo obesity pillSeptember 21, 2026 Eli Lilly CEO Dave Ricks told CNBC on Monday that one-third of new GLP-1 pill patients are taking…
HHealthcare Read More Novo Nordisk rebrands to ‘Novo’ under CEO Mike DoustdarSeptember 14, 2026 People walk past a sign for Novo Nordisk’s annual general meeting at the entrance to the venue in…